Cargando…

Pembrolizumab-Induced Myasthenia Gravis: A Case Report and Review of the Literature

Myasthenia gravis (MG) is one of the most common neuromuscular adverse effects of immune checkpoint inhibitors (ICIs) and can result in significant morbidity and mortality when it affects the bulbar and respiratory muscles. Diagnosing immune-related MG (irMG) is challenging due to its nonspecific pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eglenen Polat, Buse, Safi, Danish, Hafez, Maria, Kamran, Amir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2023
Materias:	Internal Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378713/ https://www.ncbi.nlm.nih.gov/pubmed/37519591 http://dx.doi.org/10.7759/cureus.41087

Ejemplares similares

An Atypical Presentation of Myasthenia Gravis: A Case Report
por: Asghar, Hannan, et al.
Publicado: (2019)

A Case Report and Literature Review of New-Onset Myasthenia Gravis After COVID-19 Infection
por: Chatterjee, Tulika, et al.
Publicado: (2022)

Rituximab for Immune Checkpoint Inhibitor Myasthenia Gravis
por: Verma, Neha, et al.
Publicado: (2021)

Myasthenia Gravis Associated With COVID-19 Infection
por: Sadiq, Waleed, et al.
Publicado: (2023)

Choices and Challenges With Treatment of Myasthenia Gravis in Pregnancy: A Systematic Review
por: Kumar, Lakshya, et al.
Publicado: (2023)

Myasthenia Gravis Related to Small Cell Lung Carcinoma
por: López-Viñas, Laura, et al.
Publicado: (2021)

Coexistence of Pernicious Anemia and Myasthenia Gravis Presenting As Dyspnea
por: Khademolhosseini, Sara, et al.
Publicado: (2021)

Seropositive Muscle-Specific Tyrosine Kinase Myasthenia Gravis Presenting as a Late-Onset Isolated Sixth Nerve Palsy: A Case Report and a Brief Review of Subtypes of Myasthenia Gravis
por: Park, Gyusik, et al.
Publicado: (2021)

Rituximab in the Management of Refractory Myasthenia Gravis and Variability of Its Efficacy in Anti-MuSK Positive and Anti-AChR Positive Myasthenia Gravis
por: Bastakoti, Sanjiv, et al.
Publicado: (2021)

A Diagnostic Dilemma of Dysphonia: A Case Report on Laryngeal Myasthenia Gravis
por: Khan, Asad Ali, et al.
Publicado: (2021)

A Case of Pembrolizumab-Induced Myasthenia Gravis
por: Kosick, Thomas I, et al.
Publicado: (2023)

Symptoms of Myasthenia Gravis Obscured by Old Age and Unilateral Presentation
por: Gracey, Celeste, et al.
Publicado: (2023)

Bilateral Facial Palsy Without Ocular Muscle Involvement in Myasthenia Gravis: Case Report
por: Umair, Muhammad, et al.
Publicado: (2022)

Achalasia and Cricopharyngeal Sphincter Dysfunction in a Patient With Myasthenia Gravis: A Case Report
por: Acharya, Sudeep, et al.
Publicado: (2023)

Association Between Systemic Lupus Erythematosus and Myasthenia Gravis: Coincidence or Sequelae?
por: Raut, Sumit, et al.
Publicado: (2020)

A Case of COVID-19 Vaccine Causing a Myasthenia Gravis Crisis
por: Tagliaferri, Ariana R, et al.
Publicado: (2021)

Association Between Myasthenia Gravis and Systemic Lupus Erythematosus as a Comorbid State
por: Ali, Moeez, et al.
Publicado: (2021)

Pembrolizumab-induced Myasthenia Gravis Relapse after Immunosuppressive Therapy
por: Oshima, Yuki, et al.
Publicado: (2022)

Selective Type 2 Respiratory Failure Followed by Ocular Myasthenia Gravis Diagnosed by Ice Pack Test: A Case Report
por: Dave, Hitanshu, et al.
Publicado: (2019)

Pembrolizumab‐induced myasthenia gravis with myositis in a patient with lung cancer
por: Hibino, Makoto, et al.
Publicado: (2018)

Pembrolizumab-Induced Myasthenia Gravis and Peripheral Neuropathy: A Case Series
por: McCormack, Sean M, et al.
Publicado: (2023)

Killing Two Birds With One Stone: Successful Management With Rituximab in the Coexistence of Myasthenia Gravis and Marginal Zone Lymphoma
por: Li, Xiao, et al.
Publicado: (2023)

Pembrolizumab-Induced Myasthenia Gravis and Myositis: Literature Review on Neurological Toxicities of Programmed Death Protein 1 Inhibitors
por: Schwab, Alfred, et al.
Publicado: (2022)

Thymoma-associated Myasthenia Gravis in a Young Adult with Development of Paraneoplastic Limbic Encephalitis and Systemic Lupus Erythematosus Post-thymectomy: A Case Report
por: Liu, Robin, et al.
Publicado: (2018)

Pembrolizumab-induced Ocular Myasthenia Gravis with Anti-titin Antibody and Necrotizing Myopathy
por: Onda, Asako, et al.
Publicado: (2019)

Pembrolizumab-induced myasthenia gravis-like disorder, ocular myositis, and hepatitis: a case report
por: Tian, Chia-Yi, et al.
Publicado: (2021)

When Breathing Becomes a Challenge: A Case of Congenital Myasthenia Gravis in an Indian Neonate With a DOK-7 Gene Mutation
por: Mendpara, Vaidehi, et al.
Publicado: (2023)

Case Reports of Pembrolizumab-induced Acute Inflammatory Demyelinating Polyneuropathy
por: Manam, Rupesh, et al.
Publicado: (2018)

Pembrolizumab treatment of metastatic urothelial cancer without exacerbating myasthenia gravis
por: Ishii, Akiko, et al.
Publicado: (2020)

Pembrolizumab‐induced myasthenia gravis with myositis and presumable myocarditis in a patient with bladder cancer
por: Todo, Maki, et al.
Publicado: (2019)

Germ Cell Tumor With Somatic-Type Malignancy: A Case Report and Review of the Literature
por: Cheema, Ahmad, et al.
Publicado: (2022)

Acute Pancreatitis Secondary to Pembrolizumab-Induced Hypertriglyceridemia
por: Ashfaq, Ammar, et al.
Publicado: (2023)

Early Flare-Ups of Myasthenia Gravis After Thoracoscopic Thymectomy in a Patient Recently Receiving BNT162b2 mRNA COVID-19 Vaccination
por: Dharmasaroja, Permphan
Publicado: (2022)

Emergence of Myasthenia Gravis with Myositis in a Patient Treated with Pembrolizumab for Thymic Cancer
por: Huh, So-Young, et al.
Publicado: (2018)

Myasthenia gravis and sugammadex: A case report and review of the literature
por: Dontukurthy, Sujana, et al.
Publicado: (2020)

Simultaneous pembrolizumab-induced myasthenia gravis and myocarditis in a patient with metastatic bladder cancer: A case report
por: Takai, Manabu, et al.
Publicado: (2020)

Myocarditis and myositis/myasthenia gravis overlap syndrome induced by immune checkpoint inhibitor followed by esophageal hiatal hernia: A case report and review of the literature
por: Yin, Beibei, et al.
Publicado: (2022)

Pembrolizumab-Induced Myocarditis and Delayed Acute Inflammatory Demyelinating Polyradiculoneuropathy
por: Dalal, Fazal, et al.
Publicado: (2022)

Primary Hepatic Neuroendocrine Tumor: A Case Report and Literature Review
por: Elayan, Ahmad, et al.
Publicado: (2022)

Association of Celiac Disease With Pembrolizumab
por: Sethi, Ashish, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8clfstjoevulhda32v4lnm6abo